ANIX Reports Positive Trial Data
Anixa Biosciences reports positive data from breast cancer vaccine phase 1 trial and CAR-T phase 1 trial
ANIX Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium